Silber S
Kardiologische Gemeinschaftspraxis und Herzdiagnostikzentrum, München.
MMW Fortschr Med. 2003 Apr 24;145(17):37-40.
The measurement of the calcium score with the cardio-CT is an option for determination of the individually elevated risk of a heart attack. In contrast to cardiac catheterization, the calcium score does not assess the coronary lumen, but rather the coronary vessel wall. Therefore, cardiac catheterization and calcium scoring are not competing but complementary tests: cardiac catheterization is performed to prove coronary stenoses, i.e. in patients with angina pectoris, while cardio-CT is used for the prognostic evaluation in asymptomatic patients. Cardio-CT should not be used to determine if cardiac catheterization should be performed. Also, in patients with angina pectoris, known coronary artery disease, s/p myocardial infarction or high absolute coronary risk, there is no indication for calcium scoring with cardio-CT. The prevailing indication for cardio-CT is detection of patients at high risk of a heart attack defined as > 2% annually. The recently presented St. Francis Heart Study has shown that calcium scoring provides a significantly higher prognostic value than the traditional Framingham score.
通过心脏CT测量钙化积分是确定个体心脏病发作风险升高的一种方法。与心脏导管插入术不同,钙化积分不评估冠状动脉管腔,而是评估冠状动脉血管壁。因此,心脏导管插入术和钙化积分不是相互竞争的检查,而是互补的检查:心脏导管插入术用于证实冠状动脉狭窄,即在心绞痛患者中进行,而心脏CT用于无症状患者的预后评估。心脏CT不应被用于确定是否应进行心脏导管插入术。此外,对于心绞痛患者、已知冠状动脉疾病患者、心肌梗死后患者或绝对冠状动脉风险高的患者,也没有使用心脏CT进行钙化积分的指征。心脏CT的主要指征是检测每年心脏病发作风险>2%的高危患者。最近公布的圣弗朗西斯心脏研究表明,钙化积分比传统的弗雷明汉姆评分具有显著更高的预后价值。